Tags

Type your tag names separated by a space and hit enter

Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease.
J Neurol Neurosurg Psychiatry. 1997 Jan; 62(1):10-5.JN

Abstract

OBJECTIVES

To assess and compare the prevalence of parkinsonism and Parkinson's disease in five European populations that were surveyed with similar methodology and diagnostic criteria.

METHODS

Joint analysis of five community surveys--Gironde (France), eight centres in Italy, Rotterdam (The Netherlands), Girona (Spain), and Pamplona (Spain)--in which subjects were screened in person for parkinsonism. Overall, these surveys comprised 14,636 participants aged 65 years or older.

RESULTS

The overall prevalence (per 100 population), age adjusted to the 1991 European standard population, was 2.3 for parkinsonism and 1.6 for Parkinson's disease. The overall prevalence of parkinsonism for the age groups 65 to 69, 70 to 74, 75 to 79, 80 to 84, and 85 to 89 years was respectively, 0.9, 1.5, 3.7, 5.0, and 5.1. The corresponding age specific figures for Parkinson's disease were 0.6, 1.0, 2.7, 3.6, and 3.5. After adjusting for age and sex, the prevalence figures did not differ significantly across studies, except for the French study in which prevalence was lower. Prevalence was similar in men and women. Overall, 24% of the subjects with Parkinson's disease were newly detected through the surveys.

CONCLUSIONS

Prevalence of both parkinsonism and Parkinson's disease increased with age, without significant differences between men and women. There was no convincing evidence for differences in prevalence across European countries. A substantial proportion of patients with Parkinson's disease went undetected in the general population.

Authors+Show Affiliations

Department of Epidemiology and Biostatistics, Erasmus University Medical School, Rotterdam, The Netherlands.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

9010393

Citation

de Rijk, M C., et al. "Prevalence of Parkinsonism and Parkinson's Disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action On the Epidemiology of Parkinson's Disease." Journal of Neurology, Neurosurgery, and Psychiatry, vol. 62, no. 1, 1997, pp. 10-5.
de Rijk MC, Tzourio C, Breteler MM, et al. Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease. J Neurol Neurosurg Psychiatry. 1997;62(1):10-5.
de Rijk, M. C., Tzourio, C., Breteler, M. M., Dartigues, J. F., Amaducci, L., Lopez-Pousa, S., Manubens-Bertran, J. M., Alpérovitch, A., & Rocca, W. A. (1997). Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry, 62(1), 10-5.
de Rijk MC, et al. Prevalence of Parkinsonism and Parkinson's Disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action On the Epidemiology of Parkinson's Disease. J Neurol Neurosurg Psychiatry. 1997;62(1):10-5. PubMed PMID: 9010393.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease. AU - de Rijk,M C, AU - Tzourio,C, AU - Breteler,M M, AU - Dartigues,J F, AU - Amaducci,L, AU - Lopez-Pousa,S, AU - Manubens-Bertran,J M, AU - Alpérovitch,A, AU - Rocca,W A, PY - 1997/1/1/pubmed PY - 1997/1/1/medline PY - 1997/1/1/entrez SP - 10 EP - 5 JF - Journal of neurology, neurosurgery, and psychiatry JO - J Neurol Neurosurg Psychiatry VL - 62 IS - 1 N2 - OBJECTIVES: To assess and compare the prevalence of parkinsonism and Parkinson's disease in five European populations that were surveyed with similar methodology and diagnostic criteria. METHODS: Joint analysis of five community surveys--Gironde (France), eight centres in Italy, Rotterdam (The Netherlands), Girona (Spain), and Pamplona (Spain)--in which subjects were screened in person for parkinsonism. Overall, these surveys comprised 14,636 participants aged 65 years or older. RESULTS: The overall prevalence (per 100 population), age adjusted to the 1991 European standard population, was 2.3 for parkinsonism and 1.6 for Parkinson's disease. The overall prevalence of parkinsonism for the age groups 65 to 69, 70 to 74, 75 to 79, 80 to 84, and 85 to 89 years was respectively, 0.9, 1.5, 3.7, 5.0, and 5.1. The corresponding age specific figures for Parkinson's disease were 0.6, 1.0, 2.7, 3.6, and 3.5. After adjusting for age and sex, the prevalence figures did not differ significantly across studies, except for the French study in which prevalence was lower. Prevalence was similar in men and women. Overall, 24% of the subjects with Parkinson's disease were newly detected through the surveys. CONCLUSIONS: Prevalence of both parkinsonism and Parkinson's disease increased with age, without significant differences between men and women. There was no convincing evidence for differences in prevalence across European countries. A substantial proportion of patients with Parkinson's disease went undetected in the general population. SN - 0022-3050 UR - https://www.unboundmedicine.com/medline/citation/9010393/Prevalence_of_parkinsonism_and_Parkinson's_disease_in_Europe:_the_EUROPARKINSON_Collaborative_Study__European_Community_Concerted_Action_on_the_Epidemiology_of_Parkinson's_disease_ L2 - https://jnnp.bmj.com/lookup/pmidlookup?view=long&pmid=9010393 DB - PRIME DP - Unbound Medicine ER -